From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

New brain research could reshape our understanding of ADHD and the most common drugs that treat it.

The FDA’s new warning for stimulants used to treat ADHD cites the drugs’ high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction.

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

Approximately 3.5 million children in the USA, ages 3-17, take attention-deficit/hyperactivity disorder (ADHD) medications, most commonly stimulants. These include ...

MONDAY, June 16, 2025 (HealthDay News) — People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worried that prescribing ...

Stimulants and atomoxetine are the only effective interventions to reduce short-term adult ADHD symptoms, yet show limited evidence for long-term outcomes and quality of life improvements, according ...

May 13 (UPI) --ADHD stimulant meds don't increase children's risk of psychosis, a new study says. Analyses of stimulant prescriptions among nearly 8,400 kids with attention deficit/hyperactivity ...

What attention-deficit hyperactivity disorder (ADHD) treatment alternatives are available for a child who has an adverse reaction to stimulants? Atomoxetine (Strattera) has been ineffective. —Janine ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

Strattera is a non-stimulant medication for ADHD that works by increasing norepinephrine in your brain. Common side effects ...